Diving into Dyspigmentation: Discoloration Details and Future Directions
Dr. Andrew Alexis
Dyspigmentation is defeating….for the patient and the practitioner as it is often a secondary feature of chronic inflammatory skin diseases and often a greater challenge to manage and resolve. It is always darkest before the dawn (that line also makes us cringe) BUT we have practical pearl sunshine from JDD podcast regular Dr. Andrew Alexis, Professor of Clinical Dermatology and Vice-Chair for Diversity and Inclusion at Weill Cornell Medicine in New York City. From painting realistic expectations to practical hyperpigmentation practice pearls, Dr. Alexis and JDD Podcast host Dr. Adam Friedman cover the visible spectrum. What’s new you may ask? Oh plenty, but you will only pick it up if you pump up the podcast volume.
This podcast is funded by La Roche Posay.
Listen Now
HOST: Adam Friedman, MD, FAAD
GUEST: Dr. Andrew Alexis
You May Also Like
Corticosteroids have been the effective, accessible, and familiar backbone of dermatologic therapy for decades. But with great power comes great responsibility. In this episode, podcast host Dr. Adam Friedman, Professor…
Sunscreen ... our daily epi/dermal defense, our solar safeguard, our broad-spectrum BFF for life. Yet lurking in the shaded areas are unfounded fears: “Sunscreen causes cancer; Sunscreen is an endocrine…
Acne Vulgaris... It pops up everywhere — in clinic, in conversation, and unfortunately, on our patients’ faces/trunks. While we’ve long leaned on prescription mainstays to zap zits, there’s a new family…
Get More from the JDD Podcast
Get the latest dermatology news delivered straight to your Inbox – sign up for the JDD Newsletter.
Discover the latest research, exclusive articles from leading dermatology experts,popular Podcast episodes, free CME activities, and more!
Subscribe
